B

BioVersys AG

24 employees

BioVersys is a privately held Swiss biopharmaceutical company.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Tuberculosis
Antibiotic resistance
Small molecules
Pharmaceutical
Nosocomial infections

Date founded

2010

Funding rounds raised

Total raised

$24M

from 9 investors over 9 rounds

B

BioVersys AG raised undisclosed on April 28, 2023

Investors: Innosuisse - Schweizerische Agentur für Innovationsförderung

B

BioVersys AG raised $9.1M on January 5, 2023

Investors: AMR Action Fund

B

BioVersys AG raised $4.4M on June 1, 2021

Investors: CARB-X

B

BioVersys AG raised $24M on April 14, 2021

Investors: European Investment Bank

B

BioVersys AG raised $21M on September 1, 2020

Investors: Business Angels Switzerland

B

BioVersys AG raised $8.9M on October 29, 2019

Investors: CARB-X

B

BioVersys AG raised $5.1M on November 22, 2017

Investors: Business Angels Switzerland

B

BioVersys AG raised $2.7M on March 31, 2011

Investors: GoBeyond and EVA - the Basel start-up agency

FAQ